tiprankstipranks
Trending News
More News >
China Pharma Holdings (CPHI)
:CPHI
US Market

China Pharma Holdings (CPHI) Income Statement

Compare
275 Followers

China Pharma Holdings Income Statement

Last quarter (Q3 2025), China Pharma Holdings's total revenue was $756.22B, an increase of 68737401.73% from the same quarter last year. In Q3, China Pharma Holdings's net income was $-651.48B. See China Pharma Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 4.53M$ 7.01M$ 8.10M$ 9.64M$ 10.87M
Gross Profit
$ -1.99M$ -281.08K$ -493.92K$ 349.27K$ 1.95M
Operating Expenses
$ 2.60M$ 2.47M$ 3.06M$ 3.21M$ 4.53M
Depreciation and Amortization
$ 2.62M$ 2.75M$ 2.70M$ 3.09M$ 2.68M
EBITDA
$ -1.96M$ 8.44K$ -837.69K$ 230.34K$ 106.85K
Operating Income
$ -4.59M$ -2.75M$ -3.55M$ -2.86M$ -2.58M
Other Income/Expenses
$ -147.50K$ -327.00K$ -423.86K$ -538.97K$ -288.48K
Pretax Income
$ -4.74M$ -3.08M$ -3.97M$ -3.40M$ -2.87M
Net Income
$ -4.74M$ -3.08M$ -3.97M$ -3.40M$ -2.87M
Per Share Metrics
Basic EPS
$ -0.27$ -0.29$ -1.94$ -0.85$ -0.72
Diluted EPS
$ -0.27$ -0.29$ -1.94$ -0.85$ -0.72
Weighted Average Shares Outstanding
17.46M 10.60M 5.26M 4.61M 4.61M
Weighted Average Shares Outstanding (Diluted)
17.46M 10.60M 5.26M 4.61M 4.61M
Currency in USD

China Pharma Holdings Earnings and Revenue History